Xconomy National

Archives

by in
Entry Author Date Location
Ironwood, Forest Seek FDA Approval Erin Kutz 08/09/11 Boston
Biogen Idec Closing San Diego Center, Cadence Wins FDA Approval, Adventrx Files New Drug Application, & More San Diego Life Sciences News Bruce V. Bigelow 11/04/10 San Diego
ImmunoGen Inks $45M Deal With Novartis, Tata Leads $9.5M Sun Catalytix Deal, InfraReDx Gets $21M, & More Boston-Area Deals News Erin Kutz 10/13/10 Boston
FDA Panel Votes Against Arena’s Weight-Loss Drug, ImThera Encouraged by Early Test Results, Novartis Wins FDA Approval for MS Pill, & More San Diego Life Sciences News Bruce V. Bigelow 09/23/10 San Diego
ImmunoGen and Genentech “Empowered Antibody” Cancer Drug Fails to Garner Accelerated Approval from FDA Erin Kutz 08/27/10 Boston
FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial Succeeds, Thermo Fisher Acquires Fermentas, & More Boston-Area Life Sciences News Erin Kutz 05/28/10 Boston
Isis Extends Timeline on Cholesterol-Lowering Drug, FDA Delays Review of Cadence Pain Reliever, Fate Therapeutics Raises $30 Million, & More San Diego Life Sciences News Denise Gellene 11/19/09 San Diego
Intellikine Raises $28.5M, Cadence Awaits FDA Action, Somaxon Seeks FDA Approval Again for Insomnia Drug, & More San Diego Life Sciences News Bruce V. Bigelow 07/09/09 San Diego
Amylin Braces for Proxy Battle Amid Flurry of Filings Bruce V. Bigelow 04/09/09 San Diego
Human Tissue Startup ‘Putting the Band Together Again’ Bruce V. Bigelow 11/25/08 San Diego
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.